| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 758.53B | 712.34B | 646.70B | 651.97B | 633.35B |
| Gross Profit | 202.65B | 146.86B | 92.43B | 76.88B | 121.09B |
| EBITDA | 160.67B | 108.08B | 66.22B | 46.31B | 94.05B |
| Net Income | 91.26B | 64.66B | 25.99B | 8.51B | 52.09B |
Balance Sheet | |||||
| Total Assets | 697.48B | 657.94B | 640.63B | 631.89B | 637.88B |
| Cash, Cash Equivalents and Short-Term Investments | 58.27B | 44.47B | 32.48B | 26.82B | 29.61B |
| Total Debt | 115.62B | 168.14B | 203.02B | 221.46B | 227.13B |
| Total Liabilities | 276.57B | 317.08B | 354.61B | 370.48B | 387.82B |
| Stockholders Equity | 412.05B | 331.55B | 278.52B | 253.37B | 239.69B |
Cash Flow | |||||
| Free Cash Flow | 50.79B | 45.70B | 44.46B | 12.45B | 33.12B |
| Operating Cash Flow | 87.54B | 76.70B | 75.34B | 43.01B | 60.67B |
| Investing Cash Flow | -24.46B | -20.87B | -34.91B | -31.64B | -25.54B |
| Financing Cash Flow | -53.16B | -43.63B | -36.56B | -14.68B | -37.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥1.76T | 30.41 | 7.13% | 2.01% | 8.17% | 10.92% | |
72 Outperform | ¥2.95T | 32.36 | 13.77% | 0.97% | 6.48% | 41.06% | |
68 Neutral | ¥3.66T | 50.53 | 10.06% | 1.21% | 8.80% | 117.61% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥269.37B | 19.56 | -4.83% | 3.08% | 0.09% | ― | |
56 Neutral | ¥855.84B | -13.02 | 1.88% | 6.16% | 1.98% | -48.28% | |
49 Neutral | ¥564.53B | 29.34 | 11.66% | 1.03% | 10.58% | 7.11% |